News &amp; Updates

Use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) among adults with weight regain after metabolic and bariatric surgery (MBS) results in greater weight loss without compromising safety, according to a study.

Benralizumab provides cough, dyspnoea relief in severe asthma

In a post hoc analysis of the phase III MIRACLE trial, benralizumab relieves cough and/or dyspnoea and improves cough-specific health-related quality of life (HRQoL) in individuals with severe eosinophilic asthma (SEA).

03 Nov 2026

Early respiratory infection burden linked to atopic dermatitis

Respiratory infections in early childhood are a risk factor for atopic dermatitis (AD), and the higher the number of infections, the greater the risk, as shown in a study.

Over 40 percent of patients with delusional disorder later transition to schizophrenia

Over 10 years, 41 percent of patients initially diagnosed with delusional disorder transitioned to schizophrenia, a 10-year prospective comparison study in Hong Kong has shown. The results also showed a lower burden of adverse clinical outcomes with stable delusional disorder compared with stable schizophrenia.

03 Nov 2026

H. pylori associated with colorectal cancer risk

More than one in five colorectal cancer (CRC) cases globally could be related to exposure to Helicobacter pylori, with China having the largest absolute number of CRC cases potentially linked to the bacterium, an international collaborative study led by investigators from the University of Hong Kong (HKU) has found.

Decoded mechanism of neuromotor control paves way for future motor-rehab interventions

Researchers from the Chinese University of Hong Kong (CUHK) have resolved a long-standing debate in neuroscience on the neural origin of complex muscle coordination for voluntary movements. Their recent finding that the brain organizes individual muscles into functional "building blocks" (muscle synergies) to coordinate multiple muscle groups simultaneously, rather than by directing each muscle individually, offers transformative insights for paralysis rehabilitation and design of brain-machine interfaces (BMIs) in future

Tirzepatide, semaglutide both improve liver outcomes in adults with T2D, obesity

Tirzepatide and injectable semaglutide deliver similar effectiveness against liver disease progression and major adverse liver outcomes (MALO) among adults with overweight or obesity and type 2 diabetes (T2D), a study has shown.

Guselkumab for IBD passes muster in real world

In the real-world treatment of patients with inflammatory bowel disease (IBD), the use of guselkumab yields high remission rates and has an overall safety profile that mirrors those in randomized controlled trials, according to a large prospective study.